The strategy charges fees in line with its similarly distributed peers, priced within the middle quintile.
Baron Health Care R6 BHCUX
- NAV / 1-Day Return 20.22 / −0.30 %
- Total Assets 230.8 Mil
-
Adj. Expense Ratio
0.850%
- Expense Ratio 0.850%
- Distribution Fee Level Average
- Share Class Type Retirement, Large
- Category Health
- Investment Style Large Growth
- Min. Initial Investment 5.0 Mil
- Status Open
- TTM Yield —
- Turnover 52%
USD | NAV as of May 17, 2024 | 1-Day Return as of May 17, 2024, 10:12 PM GMT+0
Morningstar’s Analysis BHCUX
Will BHCUX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 48.3
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Eli Lilly and Co | 8.44 | 20.2 Mil | Healthcare |
UnitedHealth Group Inc | 7.75 | 18.6 Mil | Healthcare |
Intuitive Surgical Inc | 5.03 | 12.1 Mil | Healthcare |
Fixed Inc Clearing Corp.Repo | 5.03 | 12.1 Mil | Cash and Equivalents |
Merck & Co Inc | 4.95 | 11.9 Mil | Healthcare |
Thermo Fisher Scientific Inc | 4.57 | 11.0 Mil | Healthcare |
Boston Scientific Corp | 4.40 | 10.5 Mil | Healthcare |
Vertex Pharmaceuticals Inc | 4.01 | 9.6 Mil | Healthcare |
argenx SE ADR | 3.29 | 7.9 Mil | Healthcare |
Rocket Pharmaceuticals Inc | 2.94 | 7.0 Mil | Healthcare |